How is peritonitis from gallbladder (cholecystic) perforation managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Peritonitis from Gallbladder Perforation

Early diagnosis of gallbladder perforation and immediate surgical intervention is essential for decreasing morbidity and mortality rates in peritonitis from gallbladder perforation. 1

Diagnosis

Clinical Presentation

  • Symptoms: Abdominal pain, tenderness, distension, fever, nausea, vomiting
  • Signs: Peritoneal signs, shock (in severe cases)
  • Risk factors: Severe systemic diseases (diabetes, atherosclerotic heart disease), advanced age, delayed treatment 1, 2

Laboratory Assessment

  • Complete blood count (elevated WBC)
  • C-reactive protein (elevated)
  • Liver function tests (may show cholestatic pattern)
  • In critically ill patients: Procalcitonin, lactate levels 1

Imaging

  • CT scan is more reliable than ultrasound for diagnosing perforation 1, 2
  • Key findings: Defect in gallbladder wall, pericholecystic fluid collection, free intraperitoneal fluid
  • Sonographic "hole sign" in gallbladder wall may be visible on ultrasound 1

Classification of Gallbladder Perforation

  1. Type I (acute): Free perforation with generalized peritonitis
  2. Type II (subacute): Pericholecystic abscess with localized peritonitis
  3. Type III (chronic): Cholecysto-enteric fistula 1, 3

Management Algorithm

1. Initial Resuscitation

  • Fluid resuscitation
  • Correction of electrolyte imbalances
  • Hemodynamic stabilization

2. Antimicrobial Therapy

  • Start broad-spectrum antibiotics immediately when peritonitis is suspected 2
  • Recommended regimens:
    • Piperacillin/tazobactam (13.5g daily divided in 4 doses) 4
    • Alternative options: Tigecycline, Ciprofloxacin plus Metronidazole, Carbapenems for severe cases 2
  • Adjust based on bile culture findings
  • Duration: 5-7 days for generalized peritonitis 1

3. Definitive Management

  • Surgical intervention is the mainstay of treatment 1
    • Laparoscopic cholecystectomy is preferred when feasible 1, 2
    • Open cholecystectomy may be necessary in complicated cases or when anatomy cannot be clearly identified 1
    • Peritoneal lavage and drainage

4. Special Considerations

  • For critically ill patients unfit for immediate surgery:
    • Percutaneous cholecystostomy as a temporizing measure 1, 5
    • Percutaneous drainage of intra-abdominal collections 5
  • For severe complicated intra-abdominal sepsis:
    • Open abdomen therapy may be considered for optimal source control 2

Monitoring and Follow-up

  • Serial clinical and laboratory monitoring
  • Follow-up imaging to ensure resolution of collections
  • Monitor for complications: sepsis, organ failure, recurrent biliary issues

Outcomes and Prognosis

  • Mortality rates for gallbladder perforation: 12-16% 1, 2
  • Factors associated with worse outcomes:
    • Delayed diagnosis and treatment
    • Advanced age
    • Comorbidities
    • Type I perforation (generalized peritonitis)

Common Pitfalls

  1. Delayed diagnosis: Perforation is rarely diagnosed pre-operatively; maintain high index of suspicion 1
  2. Delayed surgical intervention: Associated with increased morbidity, mortality, ICU admission, and prolonged hospitalization 1
  3. Inadequate source control: Ensure complete drainage of collections and appropriate surgical management
  4. Inadequate antimicrobial coverage: Ensure coverage of common biliary pathogens including Enterobacteriaceae and anaerobes 6

Gallbladder perforation with peritonitis represents a surgical emergency that requires prompt diagnosis and treatment. The combination of appropriate antimicrobial therapy and timely surgical intervention is crucial for improving outcomes in these patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Cholecystitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the next step in managing a 45-year-old woman with chills, jaundice, fever, vomiting, and abdominal tenderness, who has been diagnosed with suspected cholangitis and has undergone initial treatment with intravenous (IV) fluids and been ordered nil per os (NPO)?
What is the best course of action for a patient with suspected biliary obstruction or infection, presenting with jaundice, fever, and leukocytosis?
What is the best treatment approach for a patient with acute cholangitis, gram-positive rod infection, hepatocellular injury, leukocytosis, cardiac strain, and impaired renal function?
What are the recommended antibiotics (Abx) for the treatment of cholecystitis?
What is the next best step for a 45-year-old woman with a history of diabetes and gallstones, presenting with jaundice, right upper quadrant (RUQ) abdominal pain, fever, nausea, vomiting, leukocytosis, hyperbilirubinemia, elevated alanine transaminase (ALT) and aspartate transaminase (AST), and biliary ductal dilation on abdominal ultrasound?
What is the significance of a high mycophenolic acid (MPA) level of 53.79 in a patient taking mycophenolate mofetil (Cellcept)?
What management is recommended for a patient with normal total osmolality and anion gap?
What is the treatment for flexor tenosynovitis?
What is the initial workup and treatment for a patient presenting with alopecia areata?
What are other medications for lipedema management?
What else can elevate mycophenolic acid (MPA) levels besides mycophenolate mofetil?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.